NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 37 filers reported holding NEUBASE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $229 | -77.0% | 1,237 | -76.3% | 0.00% | – |
Q4 2022 | $995 | – | 5,229 | +327.6% | 0.00% | – |
Q3 2022 | $0 | – | 1,223 | +502.5% | 0.00% | – |
Q2 2022 | $0 | – | 203 | +6.8% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 190 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 190 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 190 | -2.1% | 0.00% | – |
Q2 2021 | $1,000 | -97.8% | 194 | -96.9% | 0.00% | – |
Q1 2021 | $46,000 | -80.0% | 6,274 | -80.9% | 0.00% | – |
Q4 2020 | $230,000 | +0.4% | 32,827 | +8.9% | 0.00% | – |
Q3 2020 | $229,000 | +4.1% | 30,154 | +20.5% | 0.00% | – |
Q2 2020 | $220,000 | +5400.0% | 25,033 | +3805.3% | 0.00% | – |
Q1 2020 | $4,000 | – | 641 | +7022.2% | 0.00% | – |
Q4 2019 | $0 | – | 9 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 9 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |